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ABSTRACT
Objectives: Domestic violence screening is advocated
in some healthcare settings. Evidence that it increases
referral to support agencies or improves health
outcomes is limited. This study aimed to (1)
investigate the proportion of hospital patients reporting
domestic violence, (2) describe characteristics and
previous hospital attendances of affected patients and
(3) assess referrals to an in-house domestic violence
advisor from Camden Safety Net.
Design: A series of observational studies.
Setting: Three outpatient clinics at the Royal Free
London NHS Foundation Trust.
Participants: 10 158 patients screened for domestic
violence in community gynaecology, genitourinary
medicine (GUM) and HIV medicine clinics between 1
October 2013 and 30 June 2014. Also 2253 Camden
Safety Net referrals over the same period.
Main outcome measures: (1) Percentage reporting
domestic violence by age group gender, ethnicity and
clinic. (2) Rates of hospital attendances in the past
3 years for those screening positive and negative. (3)
Characteristics, uptake and risk assessment results for
hospital in-house domestic violence referrals compared
with Camden Safety Net referrals from other sources.
Results: Of the 10 158 patients screened, 57.4% were
female with a median age of 30 years. Overall, 7.1%
reported ever-experiencing domestic violence, ranging
from 5.7% in GUM to 29.4% in HIV services. People
screening positive for domestic violence had higher
rates of previous emergency department attendances
(rate ratio (RR) 1.63, 95% CI 1.09 to 2.48), emergency
inpatient admissions (RR 2.27, 95% CI 1.37 to 3.84)
and day-case admissions (RR 2.03, 95% CI 1.23 to
3.43) than those screening negative. The 77 hospital
referrals to the hospital-based domestic violence
advisor during the study period were more likely to be
taken up and to be classified as high risk than referrals
from elsewhere.
Conclusions: Selective screening for domestic violence
in high-risk hospital clinic populations has the potential
to identify affected patients and promote good uptake of
referrals for in-house domestic violence support.
INTRODUCTION
Domestic violence is common in the UK:
around 30% of women and 16% of men
have experienced some form of domestic
abuse since the age of 16 years.1 It is asso-
ciated with poor health outcomes including
acute injuries as well as chronic physical and
mental health conditions. It impacts nega-
tively on children, families and wider society2
with high human and economic costs.
Women experiencing domestic violence use
more emergency department (ED), hospital
outpatient, primary care, pharmacy and
Strengths and limitations of this study
▪ This study describes a multiagency collaborative
approach to domestic violence in a hospital that
includes routine screening in three outpatient
clinics, staff training and hosting an in-house
domestic violence advisor from a local support
service.
▪ Few previous studies have investigated whether
implementing domestic violence screening in
health settings translates to increased referrals to
specialist support services.
▪ This study shows that implementing domestic
violence screening for high-risk hospital clinic
populations identifies large numbers of people
who have experienced past or current domestic
violence. Having a hospital-based independent
domestic and sexual violence advisor enhanced
the number and uptake of referrals for domestic
violence support. Hospital referrals were more
likely to be classified as high risk than referrals
to the local domestic violence service received
from elsewhere.
▪ Study limitations include missing data on results
of some risk assessments, lack of follow-up data
on long-term health outcomes and lack of cost-
effectiveness data. These will be important areas
for future evaluation.
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specialty services including mental health services than
non-abused women.3 Despite this, domestic violence is
under-reported in healthcare settings and few victims
access domestic violence services.4
The National Institute of Health and Care Excellence
(NICE) recently published guidance on how health,
social care and related organisations should identify,
prevent and reduce domestic abuse.5 Recommendations
included creating an environment for disclosing domes-
tic violence and abuse, ensuring that trained front line
staff asked about domestic violence, and having clear
pathways for referral to specialist services. NICE recom-
mends routinely asking patients in high-risk settings
such as antenatal, sexual health, alcohol and drug ser-
vices whether they have experienced domestic violence,
regardless of presentation—an approach known as
‘selective screening’—but acknowledges that there is
insufﬁcient evidence to advocate universal screening in
all healthcare settings. The WHO adopts a similar pos-
ition, supporting selective enquiry based on clinical con-
siderations and in settings such as antenatal care, over
routine enquiry or universal screening in all healthcare
encounters.6 Recent systematic reviews suggest that while
screening for intimate partner violence in some health-
care settings increases identiﬁcation of domestic vio-
lence, it is unclear whether screening increases referrals
to support agencies, reduces violence recurrence or
improves long-term health outcomes.7 8
At the Royal Free London NHS Foundation Trust
(RFL) we have shown that domestic violence makes a
notable contribution to assaults presenting at the ED,9
although the impact of domestic violence on patients in
other parts of the hospital is less clear. We therefore
instigated a programme of domestic violence screening
by frontline staff for patients attending three outpatient
clinics including sexual health, identiﬁed by NICE as a
high-risk setting, with onward referral to an in-house
support service as appropriate. We aimed to investigate
the proportion of screened patients reporting domestic
violence, describe characteristics and previous hospital
attendance patterns of affected patients and assess out-
comes of screening including uptake of referrals to
support services to inform design of future
interventions.
METHODS
Domestic violence screening and response
We designed a simple screening tool and referral path-
ways to specialist domestic violence support services in
collaboration with colleagues from Camden Safety Net
(CSN),10 an organisation offering conﬁdential advice
and support to people affected by domestic and sexual
violence who live, work or study in the London Borough
of Camden. We trained frontline staff working in com-
munity gynaecology, HIV medicine and genitourinary
medicine (GUM) clinics at the RFL to ask all patients
about domestic violence and signpost patients to
services. Staggered screening was introduced to GUM
on 01 October 2013, Community gynaecology on 01
December 2013 and HIV on 15 January 2014. Domestic
violence screening was already well established in mater-
nity services before these interventions, so maternity was
not included in this evaluation. From October 2013 an
independent domestic and sexual violence advisor
(IDSVA) from CSN was hosted at the hospital from
09:00 to 17:00 Monday to Friday to see referrals (regard-
less of borough of residence), and advise, train and
support staff on issues around domestic violence. We
raised awareness of the service by introducing the IDSVA
at staff meetings, distributing cards containing IDSVA
contact details and posting domestic violence pages on
the hospital intranet site. The work was coordinated
through a multidisciplinary domestic violence steering
group at the hospital, which reported to the Trust’s
Safeguarding Board.
Assessment of domestic violence status
The screening tool comprised an initial standardised
question: ‘Have you ever been emotionally or physically
hurt by your partner, ex-partner or family member?’
Asked by multidisciplinary clinic staff to all patients in a
private area when the patient was alone, this was used to
ascertain whether or not a person had ever experienced
domestic violence. For those who responded positively, a
standard follow-up question: ‘Are you still in contact with
this person, or are they still causing you or your family
issues?’ was used to determine whether domestic
violence was current or had happened in the past.
For those currently experiencing domestic violence,
suggested actions were to determine whether any vulner-
able people lived in the household and to refer as
appropriate to child or adult safeguarding leads, social
services and the IDSVA. Giving a lip salve with a domes-
tic violence helpline number on it was also recom-
mended if the patient declined a referral or was not
currently at risk, but might become so in the future.
Overview of evaluation
We ﬁrst compared numbers and characteristics of those
screening positive and negative for domestic violence at
the three RFL clinics, including patterns of previous
RFL attendance, to quantify potential missed opportun-
ities for identifying domestic violence. Second, we inves-
tigated referrals for domestic violence support by
comparing characteristics of affected patients referred to
the hospital IDSVA (some identiﬁed through screening;
some identiﬁed through other routes) with CSN refer-
rals from other sources for example, the police and
social services.
Data sources
Screening data
Data on domestic violence screening were collected by
staff in community gynaecology clinics, HIV and GUM
clinics at the RFL between 1 October 2013 and 30 June
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2014—a period judged sufﬁcient to embed the IDSVA
service within the hospital. Paper-based forms (used in
community gynaecology and HIV clinics) included date,
location and result of screening as well as a patient’s
medical record number (MRN). MRNs were then
matched with RFL electronic records from commission-
ing data sets (accident and emergency, admitted patient
care, outpatient attendances) to obtain demographic
information and hospital attendance history. Numbers
and rates of previous attendances at the RFL in the
3 years before screening began that is, from October
2010 were calculated for ED attendances, inpatient stays
and outpatient clinic attendances (any specialty) for
those screening positive and negative. Only forms with
exact matches to MRN were included in analyses. In the
GUM clinic, screening data were collected electronically
under a patient’s unique GUM clinic number. As these
numbers cannot be matched to hospital number, the
GUM clinic database was interrogated separately to
obtain information on demographics and history of
GUM attendances only.
Domestic violence service data
For domestic violence referrals to CSN received
between 1 October 2013 and 30 June 2014, an
anonymous data set was extracted from the CSN data-
base containing information on month and source of
referral, client demographics, whether a referral was
taken up, outcomes of any risk assessment and actions
taken.
Data analysis
Descriptive statistics were used to summarise numbers
and characteristics of patients screening positive and
negative for domestic violence by clinic, age group,
gender and ethnicity. The proportion screening positive
was expressed as the number who reported ever-
experiencing domestic violence over the number with a
valid screening result. We combined ‘current’ and ‘past’
experience as ‘any domestic violence’ partly due to data
recording differences between clinics and because we
suspected that some cases reported ‘in the past’ were
actually current. We then compared past hospital attend-
ance rates (presented per 100 000 person years of
follow-up) between those screening positive and negative
separately for ED attendances, inpatient stays and out-
patient clinic appointments. We calculated rate ratios
(RRs) with their 95% CIs and p values from signiﬁcance
tests based on a negative binomial model to accommo-
date overdispersion. Where there was evidence of differ-
ences in results by clinic, we presented results separately
by clinic. We used χ2 tests to quantify any differences in
demographic characteristics, referral uptake and risk
assessment results between people referred to the
hospital-based IDSVA and those referred to CSN from
other sources.
RESULTS
Domestic violence screening
Up to 30 June 2014, 10 183 people attending commu-
nity gynaecology, HIV and GUM clinics at the RFL
had a domestic violence screening status recorded. Of
these, 25 were excluded due to data recording incon-
sistencies leaving 10 158 screened patients included in
analyses. These represented 517 attendees at commu-
nity gynaecology clinics, 316 at HIV clinics and 9325 at
GUM clinics. Of the 10 158 screened patients, 5834
(57.4%) were female and the median age was 30 years
(IQR 25–38).
Across all clinics, 718 (7.1%) patients screened
reported ever-experiencing domestic violence.
Figures varied substantially by clinic, ranging from 5.7%
in GUM to 19.0% in community gynaecology to 29.4%
in HIV (table 1). The proportion ever-experiencing
domestic violence increased with age from 5.8% across
all clinics in those aged 16–24 years to 9.2% in those
aged over 65 years. Overall, women were 2.5 times more
likely to report domestic violence than men (9.5% com-
pared with 3.8%).
Previous hospital attendances among screened population
ED attendances
For the 833 patients screened in community gynaecol-
ogy and HIV, a slightly higher percentage of those
screening positive for domestic violence had at least one
ED attendance at RFL for any reason in the preceding
3 years than those screening negative: 51 (26.7%) vs 143
(22.3%), but this difference was not statistically signiﬁ-
cant (p=0.24). Across both clinics, however, overall rates
of previous ED attendances were higher for people
screening positive for domestic violence than for those
screening negative: RR 1.63 (95% CI 1.09 to 2.48,
p=0.019). This was based on 25 829 ED attendances per
100 000 person years for those reporting domestic vio-
lence compared with 15 836 attendances per 100 000
person years for people with no domestic violence
history.
Inpatient spells
For the same 833 patients, there were more emergency
inpatient admissions in the 3 years preceding the start of
domestic violence screening for patients screening posi-
tive compared with those screening negative: RR 2.27
(95% CI 1.37 to 3.84, p=0.002). Rates of day-case admis-
sions (usually for elective procedures) were also higher
among those screening positive: RR 2.03 (95% CI 1.23
to 3.43, p=0.007). In contrast, these patients had slightly
lower rates of other elective admissions: RR 0.29 (95%
CI 0.09 to 1.07, p=0.049). Table 2 shows ﬁgures by clinic
and admission type.
Outpatient attendances
Patients with HIV who screened positive for domestic vio-
lence had slightly higher rates of previous outpatient
attendances across various specialties than those who
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screened negative: RR 1.24 (95% CI 1.01 to 1.54),
p=0.04. For community gynaecology patients, however,
rates of outpatient department attendances were not sig-
niﬁcantly different between those screening positive and
those screening negative (although numbers were
smaller): RR 1.04 (95% CI 0.62 to 1.88) p=0.88 (table 3).
GUM patients who screened positive for domestic vio-
lence had a higher rate of attendance at the GUM clinic
in the preceding 3 years than those screening negative:
RR 1.27 (95% CI 1.09 to 1.49), p=0.002.
CSN data
Over the study period there were 77 referrals to the
hospital-based IDSVA, from a range of departments
including those not formally participating in domestic
violence screening compared with 0 CSN referrals from
the hospital in the preceding 8 months. Ages of people
referred to the hospital IDSVA ranged from 16 to 79 years
(median 29; IQR 25–45) and were not signiﬁcantly differ-
ent to the ages of people referred to CSN from other
agencies (p=0.30). Almost all hospital IDSVA referrals
(94%) were female compared with 80% of those referred
to CSN from other sources, although two of the depart-
ments regularly screening for domestic violence saw
exclusively female patients (maternity and gynaecology).
People referred to the hospital IDSVA were more likely to
access the service than those referred to CSN from other
agencies (p<0.001) (table 4).
Risk assessment results were available for 46 of 77 hos-
pital IDSVA referrals (59.7%) compared with 530 of
Table 1 Number and percentage of patients screening positive for domestic violence (current or previous) by age group,
gender, ethnicity and clinic
Characteristic
Community gynaecology,
number of persons screening
positive (% of total screened)
HIV, number of persons
screening positive
(% of total screened)
GUM, number of
persons screening
positive (% of total
screened)
Total number
of persons
screened
Age group
0–15 0 (0) 0 (0)
118 (5.1) 2445
16–24 26 (21.0) 0 (0)
25–34 47 (21.8) 9 (28.1) 222 (5.5) 4289
35–49
25 (14.1)
57 (35.2) 137 (6.2)
3424
50+ 27 (23.1) 50 (6.7)
Gender
Female 98 (19.0) 43 (40.2) 413 (7.9) 5834
Male N/A 50 (23.9) 114 (2.8) 4324
Ethnicity
White 55 (19.9) 49 (31.2) 347 (5.4) 6882
Asian 5 (11.4)
31 (27.0)
32 (4.5)
2085
Black 19 (29.2) 65 (5.6)
Mixed/other 11 (22.4) 8 (29.6)
83 (8.2) 1191
Unknown 8 (9.6) 5 (29.4)
Total 98 (19.0) 93 (29.4) 527 (5.7) 10 158
Note that some cells have been combined due to small numbers.
GUM, genitourinary medicine.
Table 2 Incidence of inpatient spells by type of admission, screening clinic and screening status from 1 October 2010 to 1
October 2013 (n=833)
Negative screen Positive screen
Screening clinic
Type of
admission
Total
admissions
Patients
at risk
Admission
rate*
Total
admissions
Patients
at risk
Admission
rate*
Rate ratio
(95% CI)
Community
gynaecology
Day cases 54 419 4296 15 98 5102 1.19 (0.60 to 2.25)
Other
elective
76 419 6046 1 98 340 0.06 (0.00 to 0.99)
Emergency 54 419 4296 27 98 9184 2.14 (1.00 to 4.76)
Total 184 419 14 638 43 98 14 626 1.00 (0.54 to 1.94)
HIV Day cases 115 221 17 345 87 92 31 522 1.81 (0.92 to 3.76)
Other
elective
28 221 4223 8 92 2899 0.69 (0.21 to 2.32)
Emergency 69 221 10 407 56 92 20 290 1.95 (1.00 to 3.87)
Total 212 221 31 976 151 92 54 710 1.71 (1.02 to 2.94)
Note patients with more than 150 spells were excluded from the analysis.
*Per 100 000 person years.
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2176 people (24.4%) referred from other sources. For
those who underwent a risk assessment, risk scores were
higher in people referred from the hospital than those
referred from elsewhere (p<0.001) (table 5).
Those accessing the hospital IDSVA received a range
of interventions including advice and safety planning,
onward referral to local support services or specialist ser-
vices (eg, rape crisis, MARAC—Multi-Agency Risk
Assessment Conference) and practical support around
obtaining injunctions and criminal prosecutions.
DISCUSSION
Through this work we show that implementing selective
domestic violence screening by frontline hospital clinic
staff for high-risk groups successfully identiﬁes people
who have experienced past or current domestic violence.
Although only 7.1% of patients reported experiencing
domestic violence overall, ﬁgures differed by setting,
reaching 29.4% among patients attending HIV medicine
clinics, where 23.9% of men and 40.2% of women
reported ever-experiencing domestic violence. People
reporting domestic violence had presented more fre-
quently to the same hospital in previous years suggesting
that there are multiple opportunities for intervention, in
particular in the ED or during emergency inpatient
stays. There was also good uptake of referrals to an
in-house domestic violence service where patients
received a range of safety interventions.
Table 3 Outpatient attendances by screening clinic and screening status shown for the five most frequent specialties and
totals from 1 October 2010 to 1 October 2013 (n=833)
Negative screen Positive screen
Screening
clinic
Outpatient
specialty
Total
admissions
Patients
at risk
Admission
rate*
Total
admissions
Patients
at risk
Admission
rate*
Rate ratio
(95% CI)
Community
gynaecology
Gynaecology 585 419 46 539 104 98 35 374 0.76 (0.42 to 1.44)
General
medicine
533 419 42 403 147 98 50 000 1.18 (0.51 to 3.20)
Obstetrics 152 419 12 092 63 98 21 429 1.77 (0.44 to 11.72)
General
surgery
101 419 8035 26 98 8844 1.10 (0.38 to 3.86)
Dermatology 105 419 8353 1 98 340 0.04 (0.00 to 6.50)
Total† 2046 419 162 768 499 98 169 728 1.04 (0.62 to 1.88)
HIV Infectious
diseases
4500 223 672 646 2088 93 748 387 1.11 (0.89 to 1.40)
General
medicine
619 223 92 526 360 93 129 032 1.40 (0.84 to 2.40)
Thoracic
medicine
293 223 43 797 247 93 88 530 2.02 (0.66 to 7.48)
General
surgery
187 223 27 952 168 93 60 215 2.16 (0.66 to 8.86)
Haematology 152 223 22 720 106 93 37 993 1.68 (0.27 to 18.00)
Total† 6808 223 1 017 638 3533 93 1 266 308 1.24 (1.01 to 1.54)
*Per 100 000 person years.
†Note totals include outpatient attendances across all specialties, whereas a detailed breakdown is only shown for the top five specialties for
each screened population.
Table 4 Numbers of clients accessing domestic violence
support from the hospital compared with those referred
from other sources
Did client access
service?
IDSVA referral
from hospital
(%)
CSN referral from
other source (%)
Yes—in person 38 (49.4) 154 (7.1)
Yes—telephone
contact
17 (22.1) 567 (26.1)
Contact made but
declined further
support
13 (16.9) 386 (17.7)
No—unable to
contact
4 (5.2) 361 (16.6)
No—out of area 0 (0) 15 (0.7)
No—other reason 5 (6.5) 693 (31.9)
Total 77 2176
CSN, Camden Safety Net; IDSVA, independent domestic and
sexual violence advisor.
Table 5 Outcomes of risk assessment for people
accessing domestic violence support from the hospital
compared with those referred from other sources
Outcome of risk
assessment
IDSVA referral
from hospital
(%)
CSN referral from
other source (%)
High 13 (28.3) 75 (14.2)
Medium 24 (52.2) 133 (25.1)
Standard 9 (19.6) 322 (60.8)
Total 46 530
CSN, Camden Safety Net; IDSVA, independent domestic and
sexual violence advisor.
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Although levels of domestic violence captured in this
study are lower overall than those reported in the
British Crime Survey, in which around 23% of people
report any history of domestic violence,1 hospital
patients may be reluctant to disclose a history of domes-
tic violence to healthcare providers due to fears about
stigma or safety.11 Previous research has shown that
interview obtains fewer disclosures of domestic violence
than self-administered questionnaires,12 but our aim
was to equip staff to integrate questions about domestic
violence into a standard clinic consultation. We also
screened using a standard wording that may not
capture all forms of controlling behaviour that consti-
tute domestic violence. Nonetheless in HIV medicine
we identify a high proportion reporting domestic vio-
lence, which lends support for the model of routine
enquiry in high-risk groups. Our study shows that,
similar to national ﬁgures, women are more likely to
experience domestic violence than men.1 In our study
people subject to domestic abuse had more contact
with health services than their non-abused peers, albeit
for a range of reasons that may not be domestic vio-
lence related, which is in line with previous reports.13
Other research suggests that as the severity of violence
and control increases, formal services including health
and the police become increasingly important in man-
aging the response to domestic violence.14
There has previously been a lack of evidence that
domestic violence screening in primary care or EDs
increases referral to support agencies.15–17 We show that
having an in-house hospital screening service results in
high numbers of referrals to the hospital-based IDSVA,
and that people referred from the hospital are more
likely to take up the referral than people referred to
domestic violence services from elsewhere. We also
provide some evidence that more women experiencing
domestic violence took up IDSVA referrals than men.
We recognise that hospital referrals are not directly com-
parable to all other referrals (80% of whom are from
the police): people referred from hospital have had a
careful discussion about the merits of onward referral
with a healthcare professional; in contrast many police
referrals are triggered automatically for example, by calls
for domestic disturbances at residential properties which
may not be the result of domestic violence. Nonetheless
our intervention was successful in enabling some
patients experiencing domestic violence to seek help.
Our referrals also tended to be higher risk than referrals
from elsewhere, although numbers were small. This
might partly be explained by the higher volume of
inappropriate referrals from non-hospital sources but
could also suggest that patients attending a hospital
experience a greater degree of domestic violence which
is negatively impacting on health and/or are more
willing to take action.
There are some limitations to this study. We used rou-
tinely collected data from electronic hospital records
and the CSN database. As data were not originally
collected for research, some ﬁelds were incomplete for
example, results of risk assessments, and useful extra
information for example, on pregnancies, children or
types of abuse were not available. In addition, GUM
clinic data did not link to the main RFL hospital
records so we were unable to review rates of previous
hospital attendances for GUM patients in any other
departments. Finally, due to difﬁculties extracting data
from hospital systems we do not present a proportion
of all attendees screened. Although we demonstrated
that domestic violence screening increases uptake to a
domestic violence service, we do not have follow-up
data on long-term health outcomes, nor did we collect
information on potential harms of screening.
Nonetheless, several referrals to the hospital-based
IDSVA have resulted in successful injunctions against
perpetrators as well as criminal prosecutions, but the
need to maintain conﬁdentiality precludes further
description of these cases. In future it would be useful
to consider methods of measuring the effectiveness of
referral beyond uptake rates.
We noted several challenges associated with imple-
menting domestic violence screening in hospital, many
of which are also highlighted in WHO guidance.6 Staff
undertaking domestic violence screening need regular
training about asking and responding appropriately,
private space is necessary for people to be asked safely
without risk that the abusive partner is present and
clear integrated referral pathways to support services
are essential. Some practical challenges were identi-
ﬁed, for example, clinics in which it was difﬁcult to
get patients on their own, and competing demands on
staff time. Using paper screening forms was less effect-
ive than electronic forms, as evidenced by the larger
numbers screened in GUM where screening was elec-
tronically prompted and recorded. In future it would
be valuable to compare routine domestic violence
screening with case ﬁnding based on ‘red ﬂag’ clinical
signs, which may streamline the process in settings
such as the ED. Although having a hospital-based
IDSVA greatly increased numbers of hospital patients
accessing help, there was no IDSVA cover at evenings
or weekends, when most domestic violence incidents
occur. Lack of long-term funding for the IDSVA
service also presented a challenge to embedding the
service successfully within the hospital. Finally, we have
not assessed the cost-effectiveness of screening for
domestic violence for preventing adverse health out-
comes but this will be an important aspect of future
evaluations.
Conclusion
Selective screening for domestic violence in high-risk
clinical populations has the potential to identify affected
patients and enhance uptake of domestic violence ser-
vices where clear pathways are in place to facilitate
referral.
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